TABLE 1 Europe Gastroesophageal Reflux Disease Therapeutics Market, 2018 - 2021, USD Million
TABLE 2 Europe Gastroesophageal Reflux Disease Therapeutics Market, 2022 - 2028, USD Million
TABLE 3 Europe Gastroesophageal Reflux Disease Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 4 Europe Gastroesophageal Reflux Disease Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 5 Europe Antacids Market by Country, 2018 - 2021, USD Million
TABLE 6 Europe Antacids Market by Country, 2022 - 2028, USD Million
TABLE 7 Europe Proton Pump Inhibitors (PPIs) Market by Country, 2018 - 2021, USD Million
TABLE 8 Europe Proton Pump Inhibitors (PPIs) Market by Country, 2022 - 2028, USD Million
TABLE 9 Europe H2 Receptor Blockers Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe H2 Receptor Blockers Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Pro-kinetic Agents Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Pro-kinetic Agents Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Gastroesophageal Reflux Disease Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 14 Europe Gastroesophageal Reflux Disease Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 15 Germany Gastroesophageal Reflux Disease Therapeutics Market, 2018 - 2021, USD Million
TABLE 16 Germany Gastroesophageal Reflux Disease Therapeutics Market, 2022 - 2028, USD Million
TABLE 17 Germany Gastroesophageal Reflux Disease Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 18 Germany Gastroesophageal Reflux Disease Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 19 UK Gastroesophageal Reflux Disease Therapeutics Market, 2018 - 2021, USD Million
TABLE 20 UK Gastroesophageal Reflux Disease Therapeutics Market, 2022 - 2028, USD Million
TABLE 21 UK Gastroesophageal Reflux Disease Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 22 UK Gastroesophageal Reflux Disease Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 23 France Gastroesophageal Reflux Disease Therapeutics Market, 2018 - 2021, USD Million
TABLE 24 France Gastroesophageal Reflux Disease Therapeutics Market, 2022 - 2028, USD Million
TABLE 25 France Gastroesophageal Reflux Disease Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 26 France Gastroesophageal Reflux Disease Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 27 Russia Gastroesophageal Reflux Disease Therapeutics Market, 2018 - 2021, USD Million
TABLE 28 Russia Gastroesophageal Reflux Disease Therapeutics Market, 2022 - 2028, USD Million
TABLE 29 Russia Gastroesophageal Reflux Disease Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 30 Russia Gastroesophageal Reflux Disease Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 31 Spain Gastroesophageal Reflux Disease Therapeutics Market, 2018 - 2021, USD Million
TABLE 32 Spain Gastroesophageal Reflux Disease Therapeutics Market, 2022 - 2028, USD Million
TABLE 33 Spain Gastroesophageal Reflux Disease Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 34 Spain Gastroesophageal Reflux Disease Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 35 Italy Gastroesophageal Reflux Disease Therapeutics Market, 2018 - 2021, USD Million
TABLE 36 Italy Gastroesophageal Reflux Disease Therapeutics Market, 2022 - 2028, USD Million
TABLE 37 Italy Gastroesophageal Reflux Disease Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 38 Italy Gastroesophageal Reflux Disease Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 39 Rest of Europe Gastroesophageal Reflux Disease Therapeutics Market, 2018 - 2021, USD Million
TABLE 40 Rest of Europe Gastroesophageal Reflux Disease Therapeutics Market, 2022 - 2028, USD Million
TABLE 41 Rest of Europe Gastroesophageal Reflux Disease Therapeutics Market by Type, 2018 - 2021, USD Million
TABLE 42 Rest of Europe Gastroesophageal Reflux Disease Therapeutics Market by Type, 2022 - 2028, USD Million
TABLE 43 Key Information – Takeda Pharmaceutical Company Limited
TABLE 44 KEY INFORMATION – AstraZeneca PLC
TABLE 45 Key Information – GlaxoSmithKline PLC
TABLE 46 Key information –Johnson & Johnson
TABLE 47 Key Information – Ironwood Pharmaceuticals, Inc.
TABLE 48 Key Information – Eisai Co., Ltd.
TABLE 49 Key Information – Medigus Ltd.
TABLE 50 Key Information – Sebela Pharmaceuticals
TABLE 51 Key Information – Phathom Pharmaceuticals, Inc.
TABLE 52 Key Information – Camber Pharmaceuticals, Inc.
List of Figures
FIG 1 Methodology for the research
Unique Offerings 
